Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
63.44 USD | -2.25% | +3.46% | +15.05% |
May. 21 | Ani Pharmaceuticals Insider Sold Shares Worth $794,568, According to a Recent SEC Filing | MT |
May. 20 | ANI Pharmaceuticals Launches Kionex Suspension | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.05% | 1.23B | |
+42.60% | 748B | |
+33.30% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.96% | 245B | |
+8.78% | 211B | |
-4.38% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- (ANIP) ANI PHARMACEUTICALS Forecasts Fiscal Year 2024 Revenue Range $520M - $542M